Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NURVV was a UK-based digital health and sports wearable company that developed smart insoles and companion software for runners. Its flagship product, NURVV Run, used embedded pressure sensors and GPS-connected pods to measure biomechanics such as footstrike, pronation, cadence, balance, and step length, then delivered real-time coaching and post-run analytics. The company positioned its offering at the intersection of consumer wearables, digital health, and performance optimization, with a focus on reducing injury risk and improving running efficiency. NURVV launched commercially around 2020 and raised venture funding, but its UK entities later entered liquidation in 2023. The business does not appear to have an active drug-development pipeline and is better characterized as a wearable digital health/device company than a biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NURVV.